Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

China's vow to review U.S. GMO crops may speed seed sales

Published 2017-05-12, 05:58 p/m
© Reuters.  China's vow to review U.S. GMO crops may speed seed sales
DJI
-
DOW
-
SYENF
-
DD
-
MON
-

By Tom Polansek and Karl Plume

CHICAGO, May 12 (Reuters) - China's promise to evaluate eight varieties of U.S. genetically modified crops by the end of this month under a trade deal marks a step forward in a years-long process that has held up seed sales in the United States, the world's top grains exporter.

Every new variety of GMO crop has to win approval in export markets before it can be sold there.

China's review covers crops grown from seeds developed by major agrichemical companies, including Monsanto (NYSE:MON) Co MON.N , Dow Chemical (NYSE:DOW) DOW.N and DuPont (NYSE:DD) DD.N , the U.S. Commerce Department and the companies said on Friday. They have been stuck in the Chinese approval process for up to six years. AgroSciences said Chinese approval would be key to the roll out of its new Enlist corn and soybeans seeds in the United States, where over 90 percent of corn is genetically modified.

China was the top export market for U.S. agriculture products, valued at over $21 billion, in 2016 and is the world's biggest buyer of soybeans. It has roiled markets and sent prices sliding in the past when it has taken a tough line on imports of certain GMO products.

In November 2013, China began rejecting U.S. corn shipments because Chinese inspectors said they contained a GMO corn variety made by Syngenta AG SYNN.S called Agrisure Viptera. The variety was approved by the United States but not China.

A U.S. trial over the matter is set to start this summer, with farmers suing Syngenta after corn prices allegedly fell because of the rejections, which cost the agriculture industry up to $2.9 billion in lost sales and lower prices.

Agrichemical companies have since taken a careful approach to launching products. For Enlist, Dow AgroSciences has restricted sales to U.S. customers during China's review.

Chief Executive Tim Hassinger said he was "very encouraged by the progress announced by the U.S. and Chinese governments."

Monsanto makes four of the products pending approval, including herbicide-tolerant corn, soybean and alfalfa varieties that have been under review for almost five years, spokeswoman Christi Dixon said.

DuPont Pioneer and Syngenta each make one of the other products pending approval, according to biotech industry group BIO.

The development on GMO crops accompanied news that China will also resume U.S. beef imports by mid-July after banning them due to a scare over mad cow disease in 2003. year, the United States exported $10 million worth of beef to China. China's imports climbed to $2.3 billion by 2015 from suppliers in Brazil, Argentina, Canada and Australia. Friday, a representative of Chinese buyers was already seeking to meet Illinois beef producers because of the new trade deal, according to the Illinois Farm Bureau.

(Editing by Cynthia Osterman)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.